Rasmus Molander
rasmus.molander@adelisequity.comRasmus joined Adelis in 2013. Rasmus is a board member at SSI Diagnostica Group, Nordic Biosite Group, Ropo Capital, re:mount and Puuilo. Previous Adelis board positions include Med Group (Chairman), Valtti, NGI and QMG. Rasmus is also a board member at Dayton Group (Chairman).
Prior to joining Adelis, Rasmus worked as an Investment Executive at Permira focusing on Healthcare and the Nordics as well as in several positions (most recently project leader) at the Boston Consulting Group (BCG).
Education: MSc (industrial engineering and biotechnology), Helsinki University of Technology and MBA (Baker Scholar), Harvard Business School